Carna Biosciences Management
Management criteria checks 2/4
Carna Biosciences' CEO is Kohichiro Yoshino, appointed in Apr 2003, has a tenure of 21.58 years. directly owns 1.75% of the company’s shares, worth ¥103.51M. The average tenure of the management team and the board of directors is 12.8 years and 6.8 years respectively.
Key information
Kohichiro Yoshino
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 21.6yrs |
| CEO ownership | 1.7% |
| Management average tenure | 12.8yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
Carna Biosciences, Inc. (TSE:4572) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Aug 06
What Carna Biosciences, Inc.'s (TSE:4572) P/S Is Not Telling You
Apr 17Health Check: How Prudently Does Carna Biosciences (TYO:4572) Use Debt?
Apr 11How Much Did Carna Biosciences'(TYO:4572) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 17Health Check: How Prudently Does Carna Biosciences (TYO:4572) Use Debt?
Dec 26
CEO
Kohichiro Yoshino (75 yo)
21.6yrs
Tenure
Dr. Kohichiro Yoshino, Ph. D. is Independent Outside Director of Kringle Pharma, Inc since December 2018. Dr. Yoshino serves as the Chief Executive Officer of Carna Biosciences, Inc. He has been President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 21.6yrs | no data | 1.75% ¥ 103.5m | |
| GM of Business Mgt. | 9.2yrs | no data | 0.29% ¥ 16.9m | |
| GM of Research & Development Division | no data | no data | 0.56% ¥ 32.9m | |
| Head of Drug Discovery & Support Business | 16.3yrs | no data | 0.53% ¥ 31.6m | |
| GM of Clinical Development | 5.8yrs | no data | 0.086% ¥ 5.1m |
12.8yrs
Average Tenure
61yo
Average Age
Experienced Management: 4572's management team is seasoned and experienced (12.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 21.6yrs | no data | 1.75% ¥ 103.5m | |
| GM of Business Mgt. | 8.7yrs | no data | 0.29% ¥ 16.9m | |
| GM of Research & Development Division | 9.7yrs | no data | 0.56% ¥ 32.9m | |
| Head of Drug Discovery & Support Business | 20.7yrs | no data | 0.53% ¥ 31.6m | |
| GM of Clinical Development | 1.7yrs | no data | 0.086% ¥ 5.1m | |
| Independent Outside Director | 4.8yrs | no data | 0.026% ¥ 1.5m | |
| Independent Outside Director | 4.8yrs | no data | 0.042% ¥ 2.5m | |
| Independent Outside Director | 9.7yrs | no data | 0.0058% ¥ 341.0k | |
| Independent Outside Director | 4.8yrs | no data | no data | |
| Independent Outside Director | less than a year | no data | no data |
6.8yrs
Average Tenure
75yo
Average Age
Experienced Board: 4572's board of directors are considered experienced (6.8 years average tenure).